Keyword: Department of Health and Human Services (HHS)
Merck, Eli Lilly and Amgen will face the HHS in appeals court Monday, looking to extend their trial court win against drug prices in TV ads.
Gilead and HHS are starting a program to provide HIV prevention meds to uninsured people who can benefit for free.
The next courtroom showdown in the battle over drug prices in TV ads is set for Jan. 13 with Merck, Eli Lilly, Amgen and ANA versus HHS.
Gilead Sciences balked at licensing the U.S. government's HIV-prevention patent rights, and now the feds are striking back.
Transparency in drug pricing sounds like a great idea, but a new study finds that almost none of the state laws provide real price insights.
The government's patents on Gilead's Truvada have made plenty of headlines lately, and that's a distraction, Gilead figures.
Health and Human Services, hoping to resurrect a rule that would force drug prices into TV ads, appealed a judge's decision that blocked it.
The Trump administration unveiled a plan to import cheaper drugs from Canada, reversing years of HHS and FDA opposition.
In his push to prove himself as the toughest 2020 candidate on Big Pharma, Donald Trump is calling for new rules on importing drugs from Canada.
Brace yourselves: Two 2020 candidates rolled tough drug-pricing plans in just two days. And rougher waters lie ahead, analysts say.